Overview

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare relative oral bioavailability of a capsule formulation of LGD-6972 to a solution formulation of LGD-6972.
Phase:
Phase 1
Details
Lead Sponsor:
Ligand Pharmaceuticals
Collaborator:
Medpace, Inc.
Treatments:
Betadex
Pharmaceutical Solutions